CRP and lymphoma: CRP is a nonspecific inflammation marker synthesized in response to acute inflammation or destruction of tissue cells, and over-expressed levels are demonstrated to be prognostic markers in various tumors, including lung, lymphoma, and, more recently, H and N cancers [25].